Archives
-
Nadolol (SQ-11725): Mechanism, Evidence & Research Workflows
2026-05-30
Nadolol (SQ-11725) is a non-selective beta-adrenergic receptor blocker widely used in hypertension and angina pectoris research. It functions by antagonizing beta-adrenergic receptors and is a substrate for OATP1A2, affecting its pharmacokinetics. This article details its molecular action, evidence base, and integration into research workflows.
-
Technical Guide: Hoechst 33342/PI Double Staining Kit (K2237
2026-05-29
The Hoechst 33342/PI Double Staining Kit enables precise distinction of viable, apoptotic, and necrotic cells in fluorescence-based research assays. It should be used for microscopy-based cell death analysis in basic research settings and is not suitable for diagnostic or clinical applications.
-
Acridine Orange hydrochloride: Technical Guide for Nucleic A
2026-05-29
Acridine Orange hydrochloride enables differential staining of DNA and RNA within live or fixed cells, supporting reliable cell cycle analysis and apoptosis detection workflows. This technical guide outlines practical setup, protocol parameters, and common troubleshooting strategies. Use is limited to nucleic acid staining applications; it is not recommended for non-nucleic acid targets or assays requiring prolonged solution stability.
-
Systematic Polypharmacology of Mitomycin C via L1000 CMap Mi
2026-05-28
Liu et al. (2018) introduce an integrated L1000-based Connectivity Map (CMap) approach to systematically identify polypharmacological drug actions and repurposing opportunities. Their findings reveal mitomycin C as a topoisomerase IIB inhibitor, highlighting the value of advanced gene-expression profiling for expanding the mechanistic landscape of established antitumor antibiotics.
-
(+)-Bicuculline: Technical Guide for GABAA Antagonist Workfl
2026-05-28
(+)-Bicuculline is a well-established GABAA receptor antagonist used for dissecting inhibitory neurotransmission and synaptic NMDA signaling in neuroscience research. It is best suited for controlled in vitro and in vivo experimental settings where precise modulation of the GABAergic signaling pathway is required. This compound is not intended for diagnostic or clinical use, and strict adherence to solubility and storage protocols is essential for reliable results.
-
Nitrocefin in Metallo-β-Lactamase Research: Advanced Assay S
2026-05-27
Explore how Nitrocefin, a chromogenic cephalosporin substrate, uniquely empowers advanced β-lactamase research, with a special focus on emerging metallo-β-lactamase dynamics and resistance transfer. Gain practical assay insights and methodological guidance beyond standard detection.
-
hiPSC-Derived Intestinal Organoids for CYP2C19 Metabolism St
2026-05-27
This study introduces a streamlined protocol for generating human pluripotent stem cell-derived intestinal organoids (hiPSC-IOs) that faithfully model human intestinal drug metabolism. The findings demonstrate that these organoids produce mature intestinal epithelial cells capable of recapitulating CYP450-mediated oxidative metabolism, offering a robust in vitro system for pharmacokinetic research.
-
iPSC-Derived Organoids Enable Pangenotype HEV Research
2026-05-26
This study establishes iPSC-induced multilineage human liver, intestinal, and brain organoids as robust in vitro models for infection and replication of hepatitis E virus (HEV) genotypes 1, 3, and 4. The findings provide new mechanistic insights into HEV pathogenesis across multiple tissues, offering a physiologically relevant platform for virology research and antiviral drug development.
-
Hypoxia Pathway Activation Restricts Measles and Nipah Virus
2026-05-26
This study demonstrates that pharmacological induction of the hypoxia response pathway, specifically via inhibition of prolyl-hydroxylase domain enzymes, effectively restricts measles and Nipah virus infections in vitro and ex vivo. The findings suggest hypoxia-inducible factor (HIF) modulation as a promising host-directed antiviral strategy, with implications for future research into metabolic pathway targeting.
-
Dexamethasone in Applied Research: Glucocorticoid Anti-infla
2026-05-25
Dexamethasone (DHAP) from APExBIO empowers precise modulation of inflammation and immune pathways for advanced neuroinflammation, stem cell, and oncology research. This guide delivers actionable protocols, troubleshooting strategies, and comparative insights for maximizing reproducibility and mechanistic clarity in cell-based and animal studies.
-
CFDA SE Cell Tracer Kit: Technical Use and Workflow Guidance
2026-05-25
The CFDA SE (carboxyfluorescein diacetate succinimidyl ester) Cell Tracer Kit addresses the need for stable, long-term fluorescent labeling in cell tracking and proliferation studies, both in vitro and in vivo. It is best suited for applications requiring covalent labeling with minimal cytotoxicity, but should not be used for reversible or short-term cell labeling workflows.
-
Aclacinomycin A: Mechanisms, Benchmarks, and Research Integr
2026-05-24
Aclacinomycin A (Aclarubicin) is a dual topoisomerase inhibitor and apoptosis inducer with well-characterized cytotoxicity across multiple cancer cell lines. It induces DNA damage and engages both caspase-3 and caspase-8 pathways, leading to apoptosis and, with prolonged exposure, necrosis. APExBIO provides rigorously validated Aclacinomycin A for high-fidelity research.
-
IGF2BP1–THBS1 Axis Regulates Macrophage Metabolism in Fibros
2026-05-23
This study reveals that the m6A reader IGF2BP1 promotes pulmonary fibrosis by stabilizing THBS1 mRNA in macrophages, driving M2 polarization and glycolytic metabolism. These mechanistic insights identify a novel IGF2BP1/THBS1/TLR4 axis as a potential therapeutic target in fibrotic lung disease.
-
Selective IRAP Inhibition via α-Hydroxy-β-Amino Acid Bestati
2026-05-22
This study presents a stereoselective synthetic strategy to develop potent, selective nanomolar inhibitors of insulin-regulated aminopeptidase (IRAP) using α-hydroxy-β-amino acid derivatives of bestatin. The findings, supported by X-ray crystallography, reveal new insights into structure-activity relationships and offer a promising direction for selective M1 aminopeptidase-targeted drug design.
-
Salmonella Haem Biosynthesis Enables Macrophage Evasion in M
2026-05-22
This study uncovers how Salmonella Typhimurium exploits a methyltransferase-driven mechanism to upregulate haem biosynthesis, suppressing macrophage phagocytosis and promoting infection. The findings redefine the role of bacterial haem as a direct modulator of host-pathogen interactions, with broad implications for immune evasion and bacterial virulence research.